Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Trends & Forecasts

Business & Regulation Trends & Forecasts

Ask, and Ye Shall Receive

| James Strachan

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

Business & Regulation Trends & Forecasts

Mergers and Big Decisions

| George Chressanthis, Randy Risser

Why the CVS-Aetna merger could be a transformative event for the pharmaceutical industry.

Business & Regulation Trends & Forecasts

Medicine Making in Europe

| Stephanie Sutton

EFPIA figures give a snapshot of drug development and innovation in Europe. Check out our infographic for some of the key stats.

Business & Regulation Business Practice

Facing the Brexit Trial

| James Strachan

No-deal Brexit poses unique challenges for the development and advanced therapy sectors, not least tight timelines and a limited ability to stockpile.

Business & Regulation Trends & Forecasts

Business-in-Brief

| Stephanie Sutton

Gene therapy deals, clinical trials transparency and sartan medicine reviews… what’s new for pharma in business?

Business & Regulation Trends & Forecasts

The Pharma Playground

| Stephanie Sutton

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

Business & Regulation Trends & Forecasts

Pharma in the Firing Line

| George Chressanthis, Charlie Thompson

With the US back to divided government, the US pharma industry could be the number one target for politicians.

Business & Regulation Drug Discovery

Here's to New Beginnings

| Stephanie Sutton

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

Business & Regulation Profession

Power to You!

| James Strachan

2019 Power List nominations close in just one month. Who’s in the running? Well, that’s up to you…

Business & Regulation Advanced Medicine

What it Takes to Bloom

| James Strachan

Cell and gene therapies can live up to their potential – the field just needs to transform medicine as we know it.


Latest White Papers

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register